Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

This study has been terminated.
(Difficulty in Recruitment)
Sponsor:
Information provided by:
pico-tesla Magnetic Therapies, LLC
ClinicalTrials.gov Identifier:
NCT00982293
First received: September 21, 2009
Last updated: May 4, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2011
  Estimated Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)